(4S)-4-methyl-2-oxo-1,3-dioxolane-4-carbonyl chloride | 934189-78-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机碳酸及其衍生物
• 英文名称: (4S)-4-methyl-2-oxo-1,3-dioxolane-4-carbonyl chloride
• CAS: 934189-78-3
• 化学式: C₅H₅ClO₄
• 分子量: 164.545
• InChiKey: XCDPWSBYGJDNJW-YFKPBYRVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (4S)-4-methyl-2-oxo-1,3-dioxolane-4-carboxylic acid 在 N,N-二甲基甲酰胺 草酰氯 作用下， 以 二氯甲烷 为溶剂， 反应 0.17h， 生成 (4S)-4-methyl-2-oxo-1,3-dioxolane-4-carbonyl chloride
  参考文献：
  名称：

  WO2007/40208

  摘要：

  公开号：

文献信息

• NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF
  申请人：NAKAI Hisao

  公开号：US20100063104A1

  公开（公告）日：2010-03-11

  It is intended to provide a compound represented by the formula (I): wherein all the symbols are as defined in the description; which has a p38 MAP kinase inhibitory activity, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. The compound of the invention is useful for preventing or treating a disease in which the abnormal production of a cytokine such as an inflammatory cytokine or a chemokine or overreaction to them is considered to be involved in the cause and aggravation of pathological conditions, in other words, an inflammatory disease, a respiratory disease, a cardiovascular disease, a central nervous system disease or the like, which is a cytokine-mediated disease.

  本发明旨在提供一种由公式（I）表示的化合物：其中所有符号如描述中所定义的；其具有p38 MAP激酶抑制活性，其盐，其N-氧化物，其溶剂合物或其前药。本发明的化合物可用于预防或治疗疾病，其中被认为异常产生细胞因子如炎症性细胞因子或趋化因子或对它们过度反应与病理情况的发生和加重有关，换句话说，是细胞因子介导的疾病，例如炎症性疾病，呼吸系统疾病，心血管疾病，中枢神经系统疾病或类似疾病。
• Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
  申请人：Ono Pharmaceuticals Co., Ltd.

  公开号：US07968572B2

  公开（公告）日：2011-06-28

  It is intended to provide a compound represented by the formula (I): wherein all the symbols are as defined in the description; which has a p38 MAP kinase inhibitory activity, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. The compound of the invention is useful for preventing or treating a disease in which the abnormal production of a cytokine such as an inflammatory cytokine or a chemokine or overreaction to them is considered to be involved in the cause and aggravation of pathological conditions, in other words, an inflammatory disease, a respiratory disease, a cardiovascular disease, a central nervous system disease or the like, which is a cytokine-mediated disease.

  本发明旨在提供一种由公式（I）表示的化合物：其中所有符号如描述中所定义的；该化合物具有p38 MAP激酶抑制活性，其盐，其N-氧化物，其溶剂化物或其前药。本发明的化合物可用于预防或治疗疾病，其中细胞因子的异常产生，如炎性细胞因子或趋化因子，或对它们的过度反应被认为是病理情况的原因和恶化，换句话说，是一种细胞因子介导的疾病，如炎症性疾病，呼吸系统疾病，心血管疾病，中枢神经系统疾病或类似疾病。
• US7968572B2
  申请人：——

  公开号：US7968572B2

  公开（公告）日：2011-06-28
• WO2007/40208
  申请人：——

  公开号：——

  公开（公告）日：——